Chicago Equity Partners’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Chicago Equity Partners’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-5,620	Closed	-$646K	–	515
2014 Q4	$646K	Sell	5,620 -8,310	-60%	-$1.01M	0.02%	299
2014 Q3	$2.18M	Sell	13,930 -21,885	-61%	-$3.17M	0.06%	213
2014 Q2	$4.42M	Buy	35,815 +11,850	+49%	+$1.31M	0.12%	158
2014 Q1	$2.48M	Buy	+23,965	New	+$2.45M	0.07%	198
2013 Q3	–	Sell	-4,330	Closed	-$286K	–	512
2013 Q2	$286K	Buy	+4,330	New	+$248K	0.01%	381

Other funds holding SLXP

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

YCMGA

York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Chicago Equity Partners's SLXP Position: Q1 2015 in Review

Chicago Equity Partners sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q1 2015, closing a stake of 5,620 shares — an estimated $646K sold.

Chicago Equity Partners first reported a position in SLXP in Q2 2013 and held it in 5 quarters. The position peaked at $4.42M in Q2 2014. 298 funds tracked by Wall St. Rank hold SLXP as of Q1 2015.

Chicago Equity Partners reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q1 2015 after selling out during the quarter.
Chicago Equity Partners sold 5,620 SALIX PHARMACEUTICALS LTD DEL shares in Q1 2015, an estimated $646K.
Chicago Equity Partners first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 5 quarters.
Chicago Equity Partners's SALIX PHARMACEUTICALS LTD DEL position peaked at $4.42M in Q2 2014.
298 funds tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q1 2015.

Based on Chicago Equity Partners's 13F filing for Q1 2015, filed 1 May 2015.